Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

38.83
-0.3900-0.99%
Post-market: 38.73-0.1000-0.26%19:59 EDT
Volume:10.82M
Turnover:422.06M
Market Cap:173.38B
PE:9.70
High:39.40
Open:39.33
Low:38.67
Close:39.22
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.05
T/O Rate:0.34%
Dividend:1.80
Dividend Rate:4.65%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.32
PE(LYR):10.72

Loading ...

From $29 To Over $200: Has Moderna Become Dangerously Overvalued?

Bellwether Stocks Movement
·
2 hours ago

From Algorithms To Oncology: Why IAM Jumped On Day One

Bellwether Stocks Movement
·
Yesterday

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
15 hours ago

Inflation Shock Sends Wall Street Lower—Why Big Pharma Became The Market’s Refuge

Sector Pulse
·
Yesterday

Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know

TradingKey
·
Yesterday

Moderately bullish activity in Novo Nordisk with shares up 2.9%

TIPRANKS
·
Oct 15

Pharma Stocks Jump. Eli Lilly, AstraZeneca up over 4%; Novo Nordisk up over 3%; Moderna, J&J, Merck, Pfizer up over 2%

Tiger Newspress
·
Oct 15

Movement Alert|Novo-Nordisk A/S Rises 3.24% in Regular Trading, GLP-1 Obesity Drug Demand Outlook Supports Pharma Names

Market Focus
·
Oct 15

South Africa Revises Rules Around Customisation of Weight-Loss Drugs

Reuters
·
Oct 15

Novo Nordisk A/S Series B Stock Falls Wednesday

Dow Jones
·
Oct 15

Walmart's List of Covered Medications Include Glp1s Like Novo's Ozempic and Lilly's Mounjaro, Alongside Some Insulin and Inhalers- Bloomberg News

THOMSON REUTERS
·
Oct 13

Moderately bullish activity in Novo Nordisk with shares down 0.48%

TIPRANKS
·
Oct 13

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Oct 13

Novo Nordisk price target lowered to $40 from $47 at BMO Capital

TIPRANKS
·
Oct 12

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

TIPRANKS
·
Oct 10

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Oct 10

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Oct 09

Novo Nordisk's Wegovy Pill to Buoy Sales, but Investors Likely to Stay Sidelined

Dow Jones
·
Oct 09

Novo Nordisk Wraps Up Real World Joint Health Study for Esperoct in Haemophilia A

TIPRANKS
·
Oct 09

1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution

Dow Jones
·
Oct 08